Pulnovo Medical Reports PADN Trial Results in NEJM
Shanghai, China, September 3, 2026 Pulnovo Medical announced clinical results from the PADN-HF-PH randomized controlled trial, evaluating pulmonary artery...
New England Journal of Medicine
Advertisement
CRISPR Therapeutics Reports Durable CTX310 Lipid Lowering
Zug, Switzerland & Boston, Mass. – August 28, 2026 CRISPR Therapeutics presented new Phase 1a durability data for CTX310,...
Latigo Biotherapeutics Reports NEJM-Published Positive LTG-001 Acute Pain Trial Results
THOUSAND OAKS, Calif., July 29, 2026 Latigo Biotherapeutics announced that The New England Journal of Medicine (NEJM) has published...
Rhythm Publishes Phase 3 IMCIVREE Data in NEJM
BOSTON, Mass., July 8, 2026 Rhythm Pharmaceuticals announced that the New England Journal of Medicine (NEJM) has published the...
Moderna Publishes Positive Phase 3 Clinical Data for mRNA-1010 Seasonal Influenza Vaccine in New England Journal of Medicine
CAMBRIDGE, Mass., May 6, 2026 Moderna announced the publication of pivotal Phase 3 clinical safety and efficacy data for...
Advertisement
